Signatur Biosciences is a biotechnology company developing precision molecular diagnostics for complex diseases, beginning with breast cancer prognosis. Its proprietary PCRchitectur platform is designed to convert standard qPCR machines into tools for analysing complex RNA or gene-expression signatures through a single streamlined assay. The company aims to make advanced diagnostics faster, cheaper and more accessible by enabling hospitals and clinical laboratories to run tests locally, rather than relying on specialised central facilities. Its services centre on diagnostic kit development, clinical testing workflows and molecular technology for oncology and other future disease areas.
This is a company profile stub. Create an account to claim your profile.
Industry
BiotechnologyAreas of Focus
Status
Active
